CompletedNot Applicable

Impact of Artificial Intelligence-Supported Educational Intervention on Mothers' Fever Management

Turkey (Türkiye)80 participantsStarted 2025-10-01

Plain-language summary

This study aims to evaluate the effect of an artificial intelligence (AI)-based educational program on mothers' fever management practices and anxiety related to fever in children. Fever is a common symptom in pediatric patients, especially under the age of three, causing repeated health concerns for parents. Despite the prevalence of fever, parents often engage in inappropriate fever management practices, which may lead to unnecessary anxiety and improper care. The study was conducted as a pretest-posttest experimental design including 80 mothers of children who presented to the Pediatric Emergency Unit at Erciyes University, Fevzi Mercan-Mustafa Eraslan Children's Hospital. Participants were assigned to either an intervention group receiving AI-supported fever management education or a control group receiving standard care. Data were collected using validated scales to assess parental fever management practices and anxiety levels before and after the intervention. The educational material was developed using ChatGPT 4.0, a large language model AI platform, and reviewed by pediatric experts. The results of this study may improve fever management education and reduce anxiety among mothers, potentially leading to better health outcomes for children.

Who can participate

Age range

18 Years – 50 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Mothers aged over 18 years, * Mothers with children aged between 6 months and 5 years, * No hearing problems, * Agree to participate in the study, * Presenting to the pediatric emergency department with a complaint of fever in their child, * Child admitted to the emergency observation room for treatment, * Able to speak and understand Turkish. Exclusion Criteria: * Illiterate mothers, * Mothers whose children have had febrile seizures, * Mothers whose children have comorbid diseases, * Mothers whose children have symptoms requiring medical intervention other than fever.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Parents' Fever Management Practices

Timeframe: Baseline and 2 weeks after intervention

Trial details

NCT IDNCT07086547

SponsorTC Erciyes University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-20

View on ClinicalTrials.gov More Fever trials